METHOD DEVELOPMENT AND VALIDATION OF DILTIAZEM IN PHARMACEUTICAL FORMS BY SPECTROPHOTOMETRIC QUANTITATIVE DETERMINATION

Authors

  • M. I. Sulyma Danylo Halytsky Lviv National Medical University
  • V. V. Ogurtsov Danylo Halytsky Lviv National Medical University
  • Yu. M. Zhuk Zaporizhia State Medical University
  • S. O. Vasyuk Zaporizhia State Medical University

DOI:

https://doi.org/10.11603/2312-0967.2017.4.8340

Keywords:

diltiazem, bromocresol green, acetone, spectrophotometric determination.

Abstract

The aim of the work. Development of quality control methods, in particular, spectrophotometric determination of the quantitative content of diltiazem in the dosage forms «Diacordin 60» and «Diacordin 90 retard» on the basis of the reaction with bromocresol green, as well as validation of the developed methods. 

Materials and Methods. The research objects are tablets «Diacordin 60» (Zentiva in SANOFI, Czech Republic, series 3010117) and tablets «Diacordin 90 Retard» (Zentiva in SANOFI, Czech Republic, series 3510317).

Reagents and solvents: A standard sample of diltiazem, bromocresol green, acetone.

Analytical equipments: Spectrophotometer Specord 200, electronic scales AVT-120-5DM, ultrasonic bath ELMASONICE60 H.

 Results and Discussion. The technique of spectrophotometric determination of the quantitative content of diltiazem in the dosage forms «Diacordin 60» and «Diacordin retard 90» based on the reaction with bromocresol green was developed. The stoichiometric ratios of the reactive components «diltiazem-BKG», obtained by the methods of continuous changes and the saturation method, completely agree with each other and amount 1:1. Based on such validation characteristics as linearity, precision, accuracy and robustness, the technique is correct and can be used in technical departments control of chemical and pharmaceutical enterprises.

 Conclusions. As a result of the work, it was found that diltiazem reacts with BKG in an acetone medium at room temperature to form a colored product with a maximum absorption at 408 nm. The investigated reaction is highly sensitive: the molar absorption coefficient is 11547, and the opening minimum is 1.79 μg / ml.

It is proved that the methodology developed by such validation characteristics as linearity, precision, correctness and robustness is correct and can be used in the departments of technical control of chemical and pharmaceutical enterprises.

 

Author Biographies

M. I. Sulyma, Danylo Halytsky Lviv National Medical University

Teaching Assistant General, bioinorganic, physical and colloidal chemistry department, Danylo Halytsky Lviv National Medical University

V. V. Ogurtsov, Danylo Halytsky Lviv National Medical University

Head of General, Bioinorganic, Physical and Colloidal chemistry department, Danylo Halytsky Lviv National Medical University

Yu. M. Zhuk, Zaporizhia State Medical University

Teaching Assistant Analytical Chemistry Department, Zaporizhia State Medical University, PhD

S. O. Vasyuk, Zaporizhia State Medical University

Head of the Analytical Chemistry Department, Zaporizhia State Medical University, PhD, DSc, Professor

References

Devarajan PV, Dhavse VV. High-performance thin-layer chromatographic determination of diltiazem hydrochloride as bulk drug and in pharmaceutical preparations. J Chromatogr B: Biomed Appl. 1998;706: 362-6.

Sultana N, Arayne MS, Shafi N A validated method for the analysis of Diltiazem in raw materials and pharmaceutical formulations by RP-HPLC Pak J Pharm Sci. 2007;20: 279-84.

Quaglia, MG, Donati E, Fanali S, et al. Analysis of diltiazem and its related substances by HPLC and HPLC/MS. J Pharm Biomed Anal. 2005;37: 695-701.

Ramchandra Krishna Pawar, Ram Lokhande, Ravi Yadav, et al. Development and validation of assay method by RP-HPLC for determination of diltiazem hydrochloride active pharmaceutical ingredient. International Journal of Chemical and Pharmaceutical Analysis. 2017;4(2).

M. Akram El-Didamony. Indirect spectrophotometric determination of diltiazem hydrochloride in pure form and pharmaceutical formulations. Central European Sci J. 2005;3(3): 520-36.

Magda M Ayad, Abdalla Shalaby, Hisham E Abdellatef et al. New colorimetric methods for the determination of trazodone HCl, famotidine, and diltiazem HCl in their pharmaceutical dosage forms. Analytical and Bioanalytical Chemistry. 2003;376(5): 710-14.

Nafisur Rahman Syed, Najmul Hejaz-Azmi. Extractive spectrophotometric methods for determination of diltiazem HCl in pharmaceutical formulations using bromothymol blue, bromophenol blue and bromocresol green. Journal of Pharmaceutical and Biomedical Analysis. 2000;24(1): 33-41.

Kamath BV, Shivram K, Shah AC. Selective spectrophotometric determination of diltiazem hydrochloride in tablets. Journal of Pharmaceutical and Biomedical Analysis. 1993;11(4-5): 407-9.

Nafisur Rahman Syed, Najmul Hejaz Azmi. Spectrophotometric determination of diltiazem hydrochloride with sodium metavanadate. Microchemical Journal. 2000;65(1): 39-43.

Bulatov MI, Kalinkin IP. Practical guide on photometric methods of analysis. 5 ed. [Практическое руководство по фотометрическим методам анализа – 5-е изд.]Lviv: Chemistry; 1986. Russian.

State Pharmacopoeia of Ukraine. [Державна фармакопея України] Kharkiv: Ukrainian Scientific Pharmacopoeia Center of Quality of Medicinal Products. 2 ed. Х; 2008. Ukrainian.

Published

2017-12-29

How to Cite

Sulyma, M. I., Ogurtsov, V. V., Zhuk, Y. M., & Vasyuk, S. O. (2017). METHOD DEVELOPMENT AND VALIDATION OF DILTIAZEM IN PHARMACEUTICAL FORMS BY SPECTROPHOTOMETRIC QUANTITATIVE DETERMINATION. Pharmaceutical Review Farmacevtičnij časopis, (4), 57–62. https://doi.org/10.11603/2312-0967.2017.4.8340

Issue

Section

Analysis of drugs